Last reviewed · How we verify

NCT03458338: RenalOne

Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa

Completed Last updated 8 March 2018
What this trial tests

trial testing estimated glomerular filtration rate and albuminuria in Chronic Kidney Diseases in 1,006 participants. Completed in 30 May 2011.

Timeline
8 December 2010
Primary endpoint
30 May 2011
30 May 2011

Quick facts

Lead sponsorUniversity Hospital, Basel, Switzerland
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,006
Start date8 December 2010
Primary completion30 May 2011
Estimated completion30 May 2011
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Basel, Switzerland

Who can join

Adults 18 to 100, any sex, with Chronic Kidney Diseases or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective cross-sectional study at the outpatient clinic (OPC) of the Bagamoyo District Hospital (BDH) in Tanzania. Assessment of basic epidemiological data (Point prevalence and risk factors) on CKD with simple clinical, laboratory tests and the patients history. After informed consent blood samples are taken for complete blood count, serum creatinine, HbA1c, HIV-Screening, and urine samples for dipstick, urine sediment, and albumin-creatinine ratio. Further, office blood pressure, weight and height are taken. Further, patients history are asked by a questionnaire (i.e.history of infectious and cardiovascular diseases and basic demographic data: i.e. sex, age). CKD is defined as the presence of either impaired kidney function and/or albuminuria based on a one-time measurement. Primary outcome of the study are prevalence rates of CKD and the impact of non-communicable and communicable disorders on CKD.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The epidemiology of chronic kidney disease and the association with non-communicable and communicable disorders in a population of sub-Saharan Africa.
    Hodel NC, Hodel NC, Hamad A, Praehauser C, et al · · 2018 · cited 36× · PMID 30379902 · DOI 10.1371/journal.pone.0205326
  2. Assessment of diabetes and prediabetes prevalence and predictors by HbA1c in a population from sub-Saharan Africa with a high proportion of anemia: a prospective cross-sectional study.
    Hodel NC, Hamad A, Reither K, Mwangoka G, et al · · 2020 · cited 6× · PMID 32439737 · DOI 10.1136/bmjdrc-2019-000939
  3. Comparison of Two Different Semiquantitative Urinary Dipstick Tests with Albumin-to-Creatinine Ratio for Screening and Classification of Albuminuria According to KDIGO. A Diagnostic Test Study.
    Hodel NC, Hamad A, Reither K, Kasella IM, et al · · 2021 · cited 2× · PMID 33419091 · DOI 10.3390/diagnostics11010081

Verify or expand the search:

Other recruiting trials for Chronic Kidney Diseases

Currently open trials in the same condition.

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03458338.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing